Crowdonomics
WatchlistPortfolio
This isn’t Bioquest Corp’s most recent raise. Private · Convertible Note · Mar 2022 (Closed) is more current.View latest round
Bioquest Corp

Reg A+ · Equity · Oct 2020

ClosedReg A+Equity
via the platform · last checked Aug 16, 2026
Raised
$0 / $5M max
0% of ceiling
Investors
—
—
Estimated pre-money
$16.2M
—

Financials disclosed in this offering

FY2019 · hover for source
$0
−$359K
FY2019
RevenueNet income
Metric
FY2019
Income statement
Revenue
$0
Cost of goods sold
$0
Net income
-$359,029
Balance sheet
Cash
$166
Accounts receivable
$0
Total assets
$166
Long-term debt
$40,000
Total liabilities
$138,745
Other
Headcount
6

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

1 amendment
  1. Nov 18, 2020
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. Form 1-A amendments state no reason; those filed before qualification are usually responses to SEC staff review.

Deal terms

Est. pre-money$16.2M
Price / share$2.00
Shares offered2,500,000

Estimated, not stated: $2.00 × 8,104,233 securities outstanding.

Offering details

Target—
Max$5,000,000
Min investment—
OpenedOct 21, 2020
Deadline—
ClosedMay 15, 2024
Days active1,302

Links & provenance

SEC filing
Source: SEC EDGAR
0001493152-20-019751
Last synced Aug 16, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.